Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01805492 · ClinicalTrials.gov registry record · NA
Global Profiling of Gene and Protein Expression Associated With Coronary Heart Disease Reversal
A NA study of Cardiovascular Diseases and Heart Diseases, sponsored by Windber Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 422
- Enrollment target
- 1
- Study location
NCT01805492 is a NA study of Cardiovascular Diseases and Heart Diseases that has completed, run by Windber Research Institute. The registered enrollment target is 422 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01805492, a NA study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Windber Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 422 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize changes in gene and protein expression in peripheral blood in patients with, or at risk for, heart disease during an intensive lifestyle modification program.
Conditions Studied
Interventions
- BEHAVIORAL Dr. Dean Ornish Program for Reversing Heart Disease
Study Locations (1)
Pennsylvania
- Windber Medical Center - Windber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2000-01 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01805492
The ClinicalTrials.gov registry entry for NCT01805492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 422 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The listed sponsor is Windber Research Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Dr. Dean Ornish Program for Reversing Heart Disease is the first listed.
NCT01805492 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01805492 about?
NCT01805492 is a clinical study titled "Global Profiling of Gene and Protein Expression Associated With Coronary Heart Disease Reversal". The purpose of this study is to characterize changes in gene and protein expression in peripheral blood in patients with, or at risk for, heart disease during an intensive lifestyle modification program.
What is the current status of trial NCT01805492?
This trial is currently completed. It is a NA study. The enrollment target is 422 participants. The study started on 2000-01. Estimated completion is 2009-02.
What conditions does trial NCT01805492 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases.
What interventions are being tested in trial NCT01805492?
The interventions under investigation include: Dr. Dean Ornish Program for Reversing Heart Disease (BEHAVIORAL).
Who is sponsoring clinical trial NCT01805492?
This trial is sponsored by Windber Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01805492 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.